JGP Global Gestao de Recursos’s ProQR Therapeutics PRQR Stock Holding History

JGP Global Gestao de Recursos’s Portfolio PRQR Stock Details PRQR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-16,433	Closed	-$228K	–	75
2019 Q1	$228K	Buy	16,433 +1,563	+11%	+$23.3K	0.08%	57
2018 Q4	$235K	Sell	14,870 -748	-5%	-$13.7K	0.29%	43
2018 Q3	$302K	Buy	+15,618	New	+$166K	0.51%	18

Other funds holding PRQR

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ACM

Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

JGP Global Gestao de Recursos's PRQR Position: Q2 2019 in Review

JGP Global Gestao de Recursos sold out of ProQR Therapeutics (PRQR) in Q2 2019, closing a stake of 16,433 shares — an estimated $228K sold.

JGP Global Gestao de Recursos first reported a position in PRQR in Q3 2018 and held it in 3 quarters. The position peaked at $302K in Q3 2018. 55 funds tracked by Wall St. Rank hold PRQR as of Q2 2019.

JGP Global Gestao de Recursos reported no remaining ProQR Therapeutics position as of Q2 2019 after selling out during the quarter.
JGP Global Gestao de Recursos sold 16,433 ProQR Therapeutics shares in Q2 2019, an estimated $228K.
JGP Global Gestao de Recursos first reported a position in ProQR Therapeutics in Q3 2018 and held it in 3 quarters.
JGP Global Gestao de Recursos's ProQR Therapeutics position peaked at $302K in Q3 2018.
55 funds tracked by Wall St. Rank held ProQR Therapeutics as of Q2 2019.

Based on JGP Global Gestao de Recursos's 13F filing for Q2 2019, filed 19 Jul 2019.